

EN

Back



Citizens Backs CRISPR Despite $24M Casgevy Sales Miss

Stock NewsThemesCitizens Backs CRISPR Despite $24M Casgevy Sales Miss

Citizens Backs CRISPR Despite $24M Casgevy Sales Miss

Edgen Stock·Dec 18 2025, 03:45

Share to

Share to

Copy link

source:

[1] Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown (https://finance.yahoo.com/news/citizens-maint ...)

Related News

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

Dec 21 2025, 11:28

BlackSky Stock Gains 80% as Gen-3 Satellite Goes Live

BlackSky Technology (BKSY) stock has gained 80.07% year-to-date after the successful deployment of its third Gen-3 satellite, which became commercially active three weeks after launch.

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

Dec 21 2025, 07:04

Google's Dual AI Strategy Wins as OpenAI User Growth Stalls

Google's dual-track AI strategy is validated as OpenAI's focus on complex models leads to a user growth bottleneck despite revenues surpassing $19 billion.

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets

Dec 21 2025, 06:44

China's $1.076T Trade Surplus Fuels Yuan Appreciation Bets

A CITIC Securities report highlights that China's record $1.076 trillion trade surplus is driving expectations for a sustained RMB appreciation, which is expected to boost profits for import-reliant industries.